BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Vaccines

Clover Biopharmaceuticals to Produce COVID-19 Vaccine

Clover Biopharmaceuticals, Ltd. (Clover), a global clinical-stage biotechnology company developing novel vaccines and biologic therapeutic candidates, toda...

September 14, 2021 | News

J & J Ebola Vaccine booster shots showed strong immune responses

Data show the vaccine regimen induced neutralizing antibody responses in nearly all participating adults and children 21 days after the second dose Adults...

September 14, 2021 | News

GeneQuantum ,BrighGene to develop antibody immune agonist conjugates

GQ1007 is a new type of antibody-drug conjugate. It is an antibody conjugated to a potent immune agonist. In recent years, immunotherapeutic antibody drugs...

September 07, 2021 | News

Moderna Announces Submission of Data to European Medicines Agency for its COVID-19 Vaccine Booster

-Moderna, Inc. a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced it has submitted for a conditional ...

September 06, 2021 | News

WHO SEA Region to discuss pandemic, rebuilding essential health services for UHC

The Seventy Fourth Regional Committee Session of WHO South-East Asia, the annual governing body meeting of WHO in the Region, is being hosted by Nepal from...

September 03, 2021 | News

Pfizer Starts PhIII Clinical Trial in Adults for Its Vaccine Against Respiratory Syncytial Virus (RSV)

Pfizer Inc. (NYSE:PFE) today announced the initiation of RENOIR (RSV vaccine Efficacy study iNOlder adults Immunized against RSV disease), a...

September 02, 2021 | News

Thermo Fisher Scientific Awarded $192.5 Million U.S. Government Contract to Expand Domestic Pipette Tip Manufacturing

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced a $192.5 million contract award from the U.S. Dep...

September 02, 2021 | News

ZyCoV-D receives EUA for world’s 1st Plasmid DNA vaccine for COVID-19

Zydus Cadila on Friday announced that it has received Emergency Use Authorisation from the Drug Controller General of India for ZyCoV-D - the world's first...

August 23, 2021 | News

HDT Bio ,Korea’s Quratis to Co-Develop COVID-19 Vaccine in Asia

HDT Bio Corp., a developer of immunotherapies for oncology and infectious diseases, announced today an agreement with Korean biotech Quratis Inc. to co-dev...

August 18, 2021 | News

SpeeDx Expand SARS-CoV-2 Variant Analysis Pipeline

PlexPrime® SARS-CoV-2 P681R Delta is a single well research mix designed to detect the P681R spike mutation of SARS-CoV-2 found in B.1.617.2 (Delta) VO...

August 18, 2021 | News

New Capacity Helps Eliminate Bottleneck for COVID-19 Vaccines

Biotage is one of the few companies offering a complete solution and ready to go off-the-shelf products for the purification of large-scale lipi...

August 16, 2021 | News

India's first nasal vaccine for COVID-19 receives nod for Phase 2, 3 trial

India's first nasal vaccine, developed by Bharat Biotech in collaboration with the Department of Biotechnology and its PSU, the Biotechnology Industry Rese...

August 16, 2021 | News

Australian Therapeutic Goods Administration Grants Provisional Registration for Moderna’s COVID-19 Vaccine

Delivery to begin in the second half of September -Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics...

August 11, 2021 | News

Thermo Fisher Scientific Updates Customizable TaqMan SARS-CoV-2 Mutation Panel to Detect Delta and Lambda Variants

The panel enables laboratories to track known mutations by selecting from a menu of over 50 assays designed to screen for different variants. The TaqMan SA...

August 10, 2021 | News

Stay Connected